Micrus Endovascular Corp. (MEND) Posts Q3 EPS of $0.20, Beats Estimates
Tweet Send to a Friend
Micrus Endovascular Corp. (NASDAQ: MEND) reports Q3 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
